Skip to content

Drug interactions

Simvastatin + Vinblastine

Severity: Minor

Simvastatin and Vinblastine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Simvastatin may inhibit P-glycoprotein and theoretically increase vinblastine exposure, which could worsen myelosuppression or neurotoxicity. The effect is predicted rather than well documented.

What this interaction means in plain words

Simvastatin and Vinblastine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Simvastatin belongs to Cardiovascular; Vinblastine belongs to Oncology.

Evidence level: Low

Why it happens

Theoretical P-glycoprotein inhibition by simvastatin reducing vinblastine efflux.

What to do

No empirical change is needed. Monitor blood counts and neurotoxicity as in standard vinblastine care.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Simvastatin and Vinblastine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Simvastatin with Vinblastine?

MediHelp rates the interaction as minor. Simvastatin and Vinblastine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Simvastatin may inhibit P-glycoprotein and theoretically increase vinblastine exposure, which could worsen myelosuppression or neurotoxicity. The effect is predicted rather than well documented.

How serious is the interaction between Simvastatin and Vinblastine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical change is needed. Monitor blood counts and neurotoxicity as in standard vinblastine care.

What other medicines interact with Simvastatin?

MediHelp also lists interactions of Simvastatin with, for example, Atazanavir, Clarithromycin, Cobicistat. The full list is on the Simvastatin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in